Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Y Ng

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomersJ S Wolfson, D C Hooper, E Y Ng, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IVD M Breines, S Ouabdesselam, E Y Ng, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1989
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulationD C Hooper, J S Wolfson, K S Souza, et al.
Molecular Microbiology|October 29, 1998
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environmentsS N Coulter, W R Schwan, E Y Ng, et al.
Infection and Immunity|February 7, 1998
Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal modelsW R Schwan, S N Coulter, E Y Ng, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomersJ S Wolfson, D C Hooper, E Y Ng, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IVD M Breines, S Ouabdesselam, E Y Ng, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1989
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulationD C Hooper, J S Wolfson, K S Souza, et al.
Molecular Microbiology|October 29, 1998
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environmentsS N Coulter, W R Schwan, E Y Ng, et al.
Infection and Immunity|February 7, 1998
Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal modelsW R Schwan, S N Coulter, E Y Ng, et al.
Pageof 3